Обоснование эффективности применения медикопсихологической реабилитации и цифровой психофизиологической терапии в регуляции формирования атеросклеротического процесса на уровне нейропептидно-цитокиновыхзвеньев иммунной системы при полиморбидной сердечно-сосудистой патологии, протекающей на фоне расс

А. В. Герцев, Ю. Н. Закревский, В. Н. Ищук
{"title":"Обоснование эффективности применения медикопсихологической реабилитации и цифровой психофизиологической терапии в регуляции формирования атеросклеротического процесса на уровне нейропептидно-цитокиновыхзвеньев иммунной системы при полиморбидной сердечно-сосудистой патологии, протекающей на фоне расс","authors":"А. В. Герцев, Ю. Н. Закревский, В. Н. Ищук","doi":"10.15789/1563-0625-EVF-2160","DOIUrl":null,"url":null,"abstract":"Scientific medical literature has accumulated a lot of data suggesting most important components of coronary heart disease pathogenesis and hypertension to be complex triggering processes of neuro-immune and neuro-endocrine interactions. Risk factors for cardiovascular diseases at the initial stages of atherosclerosis formation cause endothelial dysfunction and trigger a cascade of immune inflammation in coronary vessels, which is based on shifting immune response towards activation of lymphocytes, with predominance of cellular immune reactions. As a rule, it results in remodeling of the vascular wall under participation of proinflammatory cytokines, shifting blood lipid balance towards atherogenicity, destabilization of atherosclerotic plaque, development of thrombosis and acute coronary syndrome. In this respect, the aim of our work was to develop treatment methods that allow, under participation of endogenous immune regulators, to change the structure of pro-atherogenic links via their interactions at the initial stages of the atherosclerotic lesion formation in chronic coronary heart disease and hypertension. To achieve this goal, 80 patients (men) were selected among the marine specialists of the ship crews serving in the Arctic latitudes and the Far North, with ischemic heart disease, stage 1 hypertension and astheno-neurotic disorders with anxiety and depressive manifestations. The groups of patients were formed as follows: Group 1 (n = 31, patients who received standard therapy with cardiotropic drugs; Group 2 (n = 29), subjects who underwent drug correction with weak tranquilizers as a part of standard cardiotropic therapy; Group 3 (n = 34), standard therapy accompanied by medical and psychological rehabilitation and digital psychophysiological therapy. Effectiveness of the treatment was studied by assessing the dynamics of parameters characterizing the neuropeptide-cytokine immune status, the markers used in the diagnostics of atherosclerosis, as well as paired relationships between them. The laboratory part of the work was represented by a set of diagnostic kits, including markers of atherosclerotic process, and test systems for determination of β-endorphin, proinflammatory cytokines (TNF α, IL-1 β, IL-6), and anti-inflammatory (IL-4, IL-10) spectrum. We have found that the use of medical and psychological rehabilitation, along with digital psychophysiological therapy contributes to optimization of neuropeptide-cytokine interactions, thus showing efficiency of cardiotropic drugs usage. It seems to correct the relationships within proatherogenic structures of immune system and pathogenetic links involved in development of atherosclerotic process in polymorbid cardiovascular pathology from marine specialists with intense workloads.","PeriodicalId":85139,"journal":{"name":"Medical immunology (London, England)","volume":"23 1","pages":"541-556"},"PeriodicalIF":0.0000,"publicationDate":"2021-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical immunology (London, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15789/1563-0625-EVF-2160","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Scientific medical literature has accumulated a lot of data suggesting most important components of coronary heart disease pathogenesis and hypertension to be complex triggering processes of neuro-immune and neuro-endocrine interactions. Risk factors for cardiovascular diseases at the initial stages of atherosclerosis formation cause endothelial dysfunction and trigger a cascade of immune inflammation in coronary vessels, which is based on shifting immune response towards activation of lymphocytes, with predominance of cellular immune reactions. As a rule, it results in remodeling of the vascular wall under participation of proinflammatory cytokines, shifting blood lipid balance towards atherogenicity, destabilization of atherosclerotic plaque, development of thrombosis and acute coronary syndrome. In this respect, the aim of our work was to develop treatment methods that allow, under participation of endogenous immune regulators, to change the structure of pro-atherogenic links via their interactions at the initial stages of the atherosclerotic lesion formation in chronic coronary heart disease and hypertension. To achieve this goal, 80 patients (men) were selected among the marine specialists of the ship crews serving in the Arctic latitudes and the Far North, with ischemic heart disease, stage 1 hypertension and astheno-neurotic disorders with anxiety and depressive manifestations. The groups of patients were formed as follows: Group 1 (n = 31, patients who received standard therapy with cardiotropic drugs; Group 2 (n = 29), subjects who underwent drug correction with weak tranquilizers as a part of standard cardiotropic therapy; Group 3 (n = 34), standard therapy accompanied by medical and psychological rehabilitation and digital psychophysiological therapy. Effectiveness of the treatment was studied by assessing the dynamics of parameters characterizing the neuropeptide-cytokine immune status, the markers used in the diagnostics of atherosclerosis, as well as paired relationships between them. The laboratory part of the work was represented by a set of diagnostic kits, including markers of atherosclerotic process, and test systems for determination of β-endorphin, proinflammatory cytokines (TNF α, IL-1 β, IL-6), and anti-inflammatory (IL-4, IL-10) spectrum. We have found that the use of medical and psychological rehabilitation, along with digital psychophysiological therapy contributes to optimization of neuropeptide-cytokine interactions, thus showing efficiency of cardiotropic drugs usage. It seems to correct the relationships within proatherogenic structures of immune system and pathogenetic links involved in development of atherosclerotic process in polymorbid cardiovascular pathology from marine specialists with intense workloads.
医学心理康复和数字心理生理治疗在多发性心血管疾病背景下免疫系统神经肽细胞因子因子水平上调节动脉粥样硬化过程形成的有效性证明
科学医学文献积累了大量数据,表明冠心病发病机制和高血压的最重要组成部分是神经免疫和神经内分泌相互作用的复杂触发过程。动脉粥样硬化形成初期心血管疾病的危险因素会导致内皮功能障碍,并引发冠状血管中的一系列免疫炎症,这是基于免疫反应向淋巴细胞活化转变,以细胞免疫反应为主。通常,在促炎细胞因子的参与下,它会导致血管壁重塑,使血脂平衡向动脉粥样硬化性转变,使动脉粥样硬化斑块不稳定,形成血栓和急性冠状动脉综合征。在这方面,我们工作的目的是开发治疗方法,在内源性免疫调节因子的参与下,通过它们在慢性冠心病和高血压动脉粥样硬化病变形成的初始阶段的相互作用,改变促动脉粥样硬化环节的结构。为了实现这一目标,在北极纬度和极北地区服役的船员的海洋专家中选择了80名患者(男性),他们患有缺血性心脏病、1期高血压和伴有焦虑和抑郁表现的软性神经症。患者分组如下:第1组(n=31),接受标准心脏药治疗的患者;第2组(n=29),接受弱镇静剂药物矫正的受试者,作为标准心脏治疗的一部分;第3组(n=34),标准治疗,辅以医学和心理康复以及数字心理生理治疗。通过评估表征神经肽细胞因子免疫状态的参数的动力学、用于诊断动脉粥样硬化的标志物以及它们之间的配对关系来研究治疗的有效性。这项工作的实验室部分由一套诊断试剂盒代表,包括动脉粥样硬化过程的标志物,以及用于测定β-内啡肽、促炎细胞因子(TNFα、IL-1β、IL-6)和抗炎(IL-4、IL-10)谱的测试系统。我们发现,医学和心理康复的使用,以及数字心理生理治疗,有助于优化神经肽-细胞因子的相互作用,从而显示出心脏药的使用效率。它似乎纠正了免疫系统的原发性结构和参与多发性心血管病理中动脉粥样硬化过程发展的致病环节之间的关系,这些关系来自于工作量大的海洋专家。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信